Navigation Links
West Nile Virus IgM Capture DxSelect

ProductsWest Nile Virus IgM Capture DxSelect
Company Focus Diagnostics
Item West Nile Virus IgM Capture DxSelect
Features 
  • IgM capture enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of human serum IgM antibodies to West Nile virus.
  • The assay utilizes a recombinant WNV antigen licensed from CDC (U.S. Centers for Disease Control and Prevention).
  • Each kit contains 96 breakaway wells and all necessary reagents and controls.
Description The Focus Diagnostics West Nile Virus IgM Capture DxSelect is intended for qualitatively detecting IgM antibodies to West Nile virus in human serum. In conjunction with the Focus Diagnostics West Nile Virus IgG DxSelect, the test is indicated for testing persons having symptoms of meningioencephalitis, as an aid in the presumptive laboratory diagnosis of West Nile virus infection. Positive results must be tested using the background subtraction method (either on the initial test or on a repeat test). Positive results must be confirmed by neutralization test, or by using the current CDC guidelines for diagnosing West Nile encephalitis.
Info Focus Diagnostics
Customer Service: 714-503-2003
Web site: http://www.focusdx.com

Related medicine products :

1. West Nile Virus IgG Capture DxSelect
2. West Nile Virus IgM Capture ELISA
3. Varicella Zoster Virus (VZV) IgG EIA
4. Pathfinder Respiratory Syncytial Virus EIA
5. Epstein-Barr Virus (EBV) Early Antigen IFA
6. Epstein-Barr Virus (EBV) VCA IgM Recombinant IFA (RIFA)
7. Epstein-Barr Virus (EBV) VCA IFA IgG
8. TaqScreen West Nile Virus Test
9. PROCLEIX® West Nile Virus (WNV) Assay
10. Measles Virus IgG
11. Measles Virus IgM
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
Medicine Products:
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for certain ... Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: